Cvitkovic E - Search Results

1

Feasibility of high-dose platinum delivery with combined carboplatin and oxaliplatin.

Llory JF, Soulie P, Cvitkovic E, Misset JL. Llory JF, et al. Among authors: cvitkovic e. J Natl Cancer Inst. 1994 Jul 20;86(14):1098-9. doi: 10.1093/jnci/86.14.1098. J Natl Cancer Inst. 1994. PMID: 8043147 No abstract available.

2

Re: Irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin.

Cvitkovic E, Marty M, Wasserman E, Cuvier C, Goldwasser F, Misset JL. Cvitkovic E, et al. J Natl Cancer Inst. 1998 Jul 1;90(13):1016-7. doi: 10.1093/jnci/90.13.1016. J Natl Cancer Inst. 1998. PMID: 9665154 No abstract available.

3

Oxaliplatin clinical activity: a review.

Misset JL, Bleiberg H, Sutherland W, Bekradda M, Cvitkovic E. Misset JL, et al. Among authors: cvitkovic e. Crit Rev Oncol Hematol. 2000 Aug;35(2):75-93. doi: 10.1016/s1040-8428(00)00070-6. Crit Rev Oncol Hematol. 2000. PMID: 10936465 Review.

4

Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignancies.

Mita C, Chatelut E, Bekradda M, Soulié P, Canal P, Misset JL, Cvitkovic E, Bugat R. Mita C, et al. Among authors: cvitkovic e. Ann Oncol. 2003 Dec;14(12):1776-82. doi: 10.1093/annonc/mdg490. Ann Oncol. 2003. PMID: 14630684 Free article. Clinical Trial.

5

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer.

Soulié P, Bensmaïne A, Garrino C, Chollet P, Brain E, Fereres M, Jasmin C, Musset M, Misset JL, Cvitkovic E. Soulié P, et al. Among authors: cvitkovic e. Eur J Cancer. 1997 Aug;33(9):1400-6. doi: 10.1016/s0959-8049(97)00122-6. Eur J Cancer. 1997. PMID: 9337681 Clinical Trial.

6

Chemotherapy for ovarian cancer.

Cvitkovic E, Misset JL. Cvitkovic E, et al. N Engl J Med. 1996 May 9;334(19):1269; author reply 1270. N Engl J Med. 1996. PMID: 8606730 No abstract available.

7

[Oxaliplatin: the first DACH platinum in clinical practice].

Soulié P, Raymond E, Brienza S, Cvitkovic E. Soulié P, et al. Among authors: cvitkovic e. Bull Cancer. 1997 Jun;84(6):665-73. Bull Cancer. 1997. PMID: 9295871 French.

8

Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patients.

Germann N, Brienza S, Rotarski M, Emile JF, Di Palma M, Musset M, Reynes M, Soulié P, Cvitkovic E, Misset JL. Germann N, et al. Among authors: cvitkovic e. Ann Oncol. 1999 Mar;10(3):351-4. doi: 10.1023/a:1008310708853. Ann Oncol. 1999. PMID: 10355582 Free article. Clinical Trial.

9

Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.

Soulié P, Garrino C, Bensmaïne MA, Bekradda M, Brain E, Di Palma M, Goupil A, Misset JL, Cvitkovic E. Soulié P, et al. Among authors: cvitkovic e. J Cancer Res Clin Oncol. 1999 Dec;125(12):707-11. doi: 10.1007/s004320050338. J Cancer Res Clin Oncol. 1999. PMID: 10592105 Clinical Trial.

10

6-Day continuous infusion of high-dose ifosfamide with bone marrow growth factors in advanced refractory malignancies.

Brain EC, Mita A, Soulié P, Errihani H, Hardy Bessard AC, Chaouche M, Alexandre J, Delord JP, Cvitkovic E, Jasmin C, Misset JL. Brain EC, et al. Among authors: cvitkovic e. J Cancer Res Clin Oncol. 1997;123(4):227-31. doi: 10.1007/BF01240320. J Cancer Res Clin Oncol. 1997. PMID: 9177496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters